Don't Jump to Albumin for Decompensated Liver Disease

June 2021

You'll be asked about the role of IV albumin in patients hospitalized with acute decompensated liver disease.

New evidence shows that giving these patients DAILY albumin to raise and maintain levels above 3 g/dL does NOT reduce infection, kidney dysfunction, or death.

Plus albumin may increase pulmonary edema risk...and costs about $120 per 25 g dose.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Liver Disease Don't Jump to Albumin for Decompensated Liver Disease
Radiology Optimize Safety With IV Contrast Agents
Substance Use Disorder Expect More Use of Buprenorphine for Opioid Use Disorder
Dosing Standardize Processes for Med Dosing in Obesity
COVID-19 Answer Questions About COVID-19 Vaccines for Kids 12 and Up
Warnings Explain New Arrhythmia Warnings for Lamotrigine
Lyme Disease Guide Antibiotics for Treatment of Lyme Disease
Cystic Fibrosis Look for Cystic Fibrosis Patients Taking Bronchitol
Ear, Nose & Throat Suggest a Stepwise Approach to Manage Epistaxis
Practice Minimize Snags With "White Bagging"

Don't Jump to Albumin for Decompensated Liver Disease

Get unlimited access through an Enterprise license

Table of Contents